Skip to main content

Select Drug Profiles

ASH 2017 - Chronic Lymphocytic Leukemia

Economic Evaluation for the United States of Ibrutinib versus Allogeneic HSCT for Patients with Relapsed or Refractory CLL with 17p Deletion

ASH 2017 - Chronic Lymphocytic Leukemia

Safety and Efficacy of the Combination of Ibrutinib and Nivolumab in Patients with Relapsed Non-Hodgkin Lymphoma or CLL

ASH 2017 - Chronic Lymphocytic Leukemia

Median 3.5-Year Follow-Up of Ibrutinib Treatment in Patients with Relapsed/Refractory Mantle-Cell Lymphoma: A Pooled Analysis

ASH 2017 - Chronic Lymphocytic Leukemia

Comparison of Costs and Healthcare Resource Utilization in Patients with CLL Treated with Frontline Ibrutinib or Chemoimmunotherapy

ASH 2017 - Chronic Lymphocytic Leukemia

Preliminary Results of Prophylactic Tocilizumab After Axicabtagene Ciloleucel (axi-cel; KTE-C19) Treatment for Patients with Relapsed/Refractory, Aggressive NHL

ASH 2017 - Chronic Lymphocytic Leukemia

Single-Agent Ibrutinib versus Chemoimmunotherapy Regimens for Treatment-Naïve Patients with CLL: A Cross-Trial Comparison

ASH 2017 - Chronic Lymphocytic Leukemia

Prolonged Improvement in PROs and Well-Being in Older Patients with Treatment-Naïve CLL Treated with Ibrutinib: 3-Year Follow-Up of the RESONATE-2 Study

"Opioids Equal Heroin"

David B. Nash, MD, MBA

David B. Nash, MD, MBA

Original Research

Major Cardiovascular Events in Patients with Gout and Associated Cardiovascular Disease or Heart Failure and Chronic Kidney Disease Initiating a Xanthine Oxidase Inhibitor

JoAnne Foody, MD, Robin S. Turpin, PhD, Beni A. Tidwell, BS, Debra Lawrence, PhD, Kathy L. Schulman, MS

JoAnne Foody, MD; Robin S. Turpin, PhD; Beni A. Tidwell, BS; Debra Lawrence, PhD; Kathy L. Schulman, MS

Stakeholder Perspective

The Growing Role of Real-World Evidence in Clinical Decision-Making

Gary M. Owens, MD

by Gary M. Owens, MD

Original Research, Practice Management

Comparing the Cost of Treatment with Octreotide Long-Acting Release versus Lanreotide in Patients with Metastatic Gastrointestinal Neuroendocrine Tumors

Rajeev Ayyagari, PhD, Maureen Neary, PhD, MS, Shang Li, MS, Ariel Rokito, BS, Hongbo Yang, PhD, Jipan Xie, MD, PhD, Al B. Benson III, MD, FACP, FASCO

Rajeev Ayyagari, PhD; Maureen Neary, PhD, MS; Shang Li, MS; Ariel Rokito, BS; Hongbo Yang, PhD; Jipan Xie, MD, PhD; Al B. Benson III, MD, FACP, FASCO

Page 78 of 244
Results 771 - 780 of 2434